Medicine preparation for treating gynecologic disease

2009
OA: closed

Abstract

The invention relates to a compound pharmaceutical preparation using natural plants as medicinal components and treating gynecologic diseases. The invention relates to an oral preparation prepared by using materials with the following weight portions: 450 portions of radix salviae miltiorrhizae, 250 portions of rhizoma zedoariae, 250 portions of bupleurum marginatum, 150 portions of pseudo-ginseng, 250 portions of red paeonia, 250 portions of angelica, 175 portions of trigone, 150 portions of rhizoma cyperi, 175 portions of fumitory and 100 portions of liquorice. The application adopts specific medicinal materials and specific amount, has reliable compositional components and the preparation has the functions of promoting blood circulation by removing blood stasis and diminishing inflammation, relieving the depressed liver, regulating menstruation and relieving pain and softening hard masses and relieving stasis. Pharmacodynamic tests prove that the compound pharmaceutical preparation can cause the atrophy and necrosis of ectopic endometrium of experimental rat endometrium to eliminate pelvic inflammatory diseases, and simultaneously the compound pharmaceutical preparation has the functions of anti-inflammatory, stopping pain, anti-platelet aggregation, and inhibiting the in vitro or spasm and contraction of uterus in vivo caused by pituitrin. The compound pharmaceutical preparation is used for treating menoxenia caused by woman blockage of blood stasis, dysmenorrhea, discomfort in menstrual period, abdominal mass accumulation and pelvic endometriosis.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-07T06:07:59.301721+00:00